Indicated for: chronic venous disease; capillary fragility
Route of administration: oral
Substance: calcium dobesilate (vasodilator)
ATC: C05BX01 (Cardiovascular system | Antivaricose therapy | Other sclerosing agents)
Calcii dobesilas is a medication used for the treatment of vascular conditions such as chronic venous insufficiency, hemorrhoids, and diabetic retinopathy. It has vasoprotective and anti-inflammatory properties, reducing capillary permeability and improving microcirculation.
The medication is taken orally, usually two or three times a day, as directed by a doctor. The dosage and duration of treatment are adjusted based on the severity of the condition and the patient's response.
Common side effects include nausea, diarrhea, abdominal pain, and mild allergic reactions. In rare cases, more severe adverse effects such as severe skin rashes or liver disorders may occur.
Calcii dobesilas is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, it is important for patients to adhere to the prescribed dosage to prevent adverse effects.